Cipla licenses ARV technology into Uganda

Afro-IP – the blog for intellectual property law, practice and policies: Some better news concerning drugs in Uganda this time: in “Technology from India makes AIDS drugs in Uganda”, by Patralekha Chatterjee, Thaindian News …reports that technology transferred by Indian generic drug maker Cipla to an unspecified Ugandan partner is jumpstarting the local manufacture of key antiretroviral (ARV) drugs to combat HIV/AIDS in that country. This is said to be an improvement over treatment by imported branded drugs — which was not only a drain on the national government but also exposed Uganda to the risk of supply disruption “if donors decided to stop supplies in case of political differences”.